Jeffrey Hung

Work

Analyst Jeffrey Hung works at MORGAN STANLEY and is focused on the Healthcare sector with 342 price targets and ratings documented since 2015 spanning on 23 stocks. Analyst's average stock valuation to be materialised ratio is 55.88% with an average time for price targets to be met of 92.39 days.

Most recent stock forecast was given on CINC, at 29-Nov-2022.

Jeffrey Hung best performing recommendations are on RYTM (RHYTHM PHARMACEUTICALS, INC).
The best stock recommendation documented was for RYTM (RHYTHM PHARMACEUTICALS, INC) at 11/9/2022. The price target of $26 was fulfilled within 2 days with a profit of $3.75 (16.85%) receiving and performance score of 84.27.

Average potential price target upside

ACAD CYTK ESPR EVFM EXEL PRLD RARE VYGR APRE BCYC JAZZ MYOK NBIX NXTC RPTX CELU CGEM CINC GRPH RUBY CYT RYTM XLRN

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

12

$-2.66 (-18.14%)

15

1 months 5 days ago

4/6 (66.67%)

$0.85 (2.86%)

40

Buy

21

$6.34 (43.25%)

21

1 months 6 days ago

1/13 (7.69%)

$10.98 (46.43%)

119

Hold

17

$2.34 (15.96%)

29

1 months 8 days ago

0/2 (0%)

$1.42 (6.71%)

Hold

19

$4.34 (29.60%)

27

3 months 29 days ago

4/12 (33.33%)

$9.9 (35.53%)

24

Buy

25

$10.34 (70.53%)

20

4 months ago

2/7 (28.57%)

$11.34 (44.92%)

136

Show more analysts
ACAD CYTK ESPR EVFM EXEL PRLD RARE VYGR APRE BCYC JAZZ MYOK NBIX NXTC RPTX CELU CGEM CINC GRPH RUBY CYT RYTM XLRN